Abstract
Ergot has been called a treasure-house of drugs; possibly no other source of biological products has so many active constituents with such a wide spectrum of pharmacological properties, which has been further expanded by the production of derivatives with qualitatively new actions. Ergot consists of the sclerotia or resting stage produced by fungi of the genus Claviceps, most commonly C. purpurea, which is principally parasitic on the rye, Secale cereale. Many other varieties of ergot are known; over 50 species of Claviceps have been described, infesting over 600 recorded host species of the family Gramineae (grasses and cereals) (Bové, 1970). Although possible allusions to ergot are found in early records (see Bové, 1970), the earliest undisputable reference to ergot itself was made in 1582 by Lonicer, who described its use in midwifery. However, it was not widely accepted by physicians until the nineteenth century. The history and pharmacognosy of ergot have been extensively reviewed by Barger (1931) and by Bové (1970).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrahams, V. C., Hilton, S. M., and Zbroiyna, A. W., 1960, Active muscle vasodilation produced by stimulation of the brain stem: Its significance in the defence reaction, J. Physiol. (Lond.) 154: 491.
Abrahams, V. C., Hilton, S. M., and Zbrozyna, A. W., 1964, The role of active muscle vasodilation in the altering stage of the defence reaction, J. Physiol. (Lond.) 171: 189.
Aeilig, W. H., and Berde, B., 1969, Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed, Brit. J. Pharmacol. 36: 561.
Aghajanian, G. K., 1972a, LSD and CNS transmission, Ann. Rev. Pharmacol. 12: 157.
Aghajanian, G. K., 1972b, Influence of drugs on the firing of serotonin-containing neurons in brain, Fed. Proc. 31: 91.
Aghajanian, G. K., 1972c, Chemical feedback regulation of serotonin-containing neurons in brain, Ann. N.Y. Acad. Sci. 193: 86.
Aghajanian, G. K., Haigler, H. J., and Bloom, F. E., 1972, Lysergic acid diethylamide and serotonin: Direct actions on serotonin-containing neurons in rat brain, Life Sci. 11:615 (Part I).
Ambache, N., Dunk, L. P., Verney, J., and Aboo Zar, M., 1973, An inhibition of postganglionic motor transmission in the mammalian vas deferens by D-lysergic acid diethylamide, J. Physiol. (Lond.) 231: 251.
Andén, N.-E., Corrodi, H., Fuxe, K., and Hökfelt, T., 1968, Evidence for a central 5- hydroxytryptamine receptor stimulation by lysergic acid diethylamide, Brit. J. Pharmacol. 34: 1.
Anderson, E. G., 1972, Bulbospinal serotonin-containing neurons and motor control, Fed. Proc. 31: 107.
Anthony, M., Hinterberger, H., and Lance, J. W., 1969, The possible relationship of serotonin to the migraine syndrome, Res. Clin. Stud. Headache 2: 29.
Appel, J. B., and Freedman, D. X., 1964, Chemically-induced alterations in the behavioral effects of LSD-25, Biochem. Pharmacol. 13: 861.
Appel, J. B., Lovell, R. A., and Freedman, D. X., 1970a, Alterations in the behavioral effects of LSD by pretreatment with p-chlorophenylalanine and α-methyl-p-tyrosine, Psychopharmacologia (Berl.) 18: 387.
Appel, J. B., Sheard, M. H., and Freedman, D. X., 1970b, Alterations in the behavioral effects of LSD by midbrain raphe lesions, Commun. Behav. Biol. 5: 237.
Arcari, G., Dorigotti, L., Fregnan, G. B., and Glässer, A. H., 1968, Vasodilating and alpha- receptor blocking activity of a new ergoline derivative, Brit. J. Pharmacol. 34: 700 P.
Avery, D. D., 1972, Thermoregulatory effects of intrahypothalamic injections of adrenergic and cholinergic substances at different environmental temperatures, J. Physiol. (Lond.) 220: 257.
Barasi, S., and Roberts, M. H. T., 1973, The action of 5-hydroxytryptamine antagonists and precursors on bulbospinal facilitation of spinal reflexes, Brain Res. 52: 385.
Barcroft, H., Konzett, H., and Swan, H. J. C., 1951, Observations on the action of the hydrogenated alkaloids of the ergotoxine group on the circulation in man, J. Physiol. (Lond.) 112: 273.
Barger, G., 1931, Ergot and Ergotism, Gurney and Jackson, London.
Beretta, C., Ferrini, R., and Glässer, A. H., 1965, l-Methyl-8β-carbobenzyloxy-aminomethyl- 10α-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist, Nature (Lond.) 207: 421.
Bergström, S., Farnebo, L.-O., and Fuxe, K., 1973, Effect of prostaglandin E2 on central and peripheral catecholamine neurons, Europ. J. Pharmacol. 21: 362.
Berridge, M. J., and Prince W. T., 1973, Mode of action of hallucinogenic molecules, Nature New Biol. 243: 283.
Bhargava, K. P., Mishra, N., and Tangri, K. K., 1972, An analysis of central adrenoceptors for control of cardiovascular function, Brit. J. Pharmacol. 45: 596.
Björklund, A., and Falck, B., 1969, Histochemical characterization of a tryptamine-like substance stored in cells of the mammalian adenohypophysis, Acta Physiol. Scand. 77: 475.
Björklund, A., and Nobin, A., 1973, Fluorescence histochemical and microspectrofluorometric mapping of dopamine and noradrenaline cell groups in the rat diencephalon, Brain Res. 51: 193.
Björklund, A., Moore, R. Y., Nobin, A., and Stenevi, U., 1973, The organisation of tuberohypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain, Brain Res. 51: 171.
Bluntschli, H. J., and Goetz, R. H., 1948, The effect of ergot derivatives on the circulation in man with special reference to two new hydrogenated compounds (dihydroergotamine and dihydroergocornine), Am. Heart J. 35: 873.
Boakes, R. J., Bradley, P. B., Briggs, I., and Dray, A., 1970, Antagonism of 5- hydroxytryptamine by LSD 25 in the central nervous system: A possible neuronal basis for the actions of LSD 25, Brit. J. Pharmacol. 40: 202.
Bolme, P., and Fuxe, K., 1973, Pharmacological studies on a possible role of central noradrenaline neurons in respiratory control, J. Pharm. Pharmacol. 25: 351.
Bolme, P., Fuxe, K., and Lidbrink, P., 1972, On the function of central catecholamine neurons-Their role in cardiovascular and arousal mechanisms, Res. Commun. Chem. Pathol. Pharmacol. 4: 657.
Borison, H. L., and Clark, W. G., 1967, Drug actions on thermoregulatory mechanisms, Advan. Pharmacol. 5: 129.
Bove, F. J., 1970, The Story of Ergot, Karger, Basel.
Bradley, P. B., and Briggs, I., 1974, Further studies on the mode of action of psychotomimetic drugs: Antagonism of the excitatory actions of serotonin by methylated derivatives of tryptamine, Brit. J. Pharmacol. 50: 345–354.
Brawley, P., and Duffield, J. C., 1972, The pharmacology of hallucinogens, Pharmol. Rev. 24: 31.
Brody, T. M., and Diamond, J., 1967, Blockade of the biochemical correlates of contraction and relaxation in uterine and intestinal smooth muscle, Ann. N. Y. Acad. Sci. 139: 772.
Bronzino, J. D., 1972, Evoked response study of postulated neural circuit associated with sleep-waking process, Life Sci. 11:419 (Part I).
Bronzino, J. D., Morgane, P. J., and Stern, W. C., 1972, EEG synchronization following application of serotonin to area postrema, Am. J. Physiol. 223: 376.
Brown, P. S., 1968, The effect of drugs on induced ovulation, J. Reprod. Fertil. Suppl. 4: 61.
Bucknell, A., and Whitney, B., 1964, A preliminary investigation of the pharmacology of the human isolated taenia coli preparation, Brit. J. Pharmacol 23: 164.
Carlsson, A., and Lindqvist, M., 1972, The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo, J. Neural Trans. 33: 23.
Cerletti, A., 1959, in: Neuropsychopharmacology, Proceedings of the First International Congress of Neuropsychopharmacology (P. B. Bradley, P. Deniker, and C. Radouco- Thomas, eds.) pp. 117–123, Elsevier, Amsterdam.
Cerletti, A., and Doepfner, W., 1958, Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids, J. Pharmacol. Exptl. Therap. 122: 124.
Chalmers, J. P., and Wurtman, R. J., 1971, Participation of central noradrenergic neurons in arterial baroreceptor reflexes in the rabbit, Circ. Res. 28: 480.
Chan, P. S., and Ellis, S., 1969, Dihydroergotamine antagonism of glucose release by rabbit liver slices induced by catecholamines, glucagon and 3,5 -AMP, Fed. Proc. 28: 742.
Chu, D., and Stuermer, E., 1973, Studies on the mechanism of action of dihydroergotamine (DHE) on the vascular bed of cat skeletal muscle, Brit. J. Pharmacol. 48: 33 I P.
Cohen, S., 1967, Psychotomimetic agents, Ann. Rev. Pharmacol. 7: 301.
Connell, P. H., 1972, Hallucinogens, in: Side Effects of Drugs, Vol. VII ( Meyler, L., Herxheimer, A., eds.) pp. 38–50, Excerpta Medica, Amsterdam.
Coote, J. H., and Macleod, V.H., 1972, The possibility that noradrenaline is a sympathoin- hibitory transmitter in the spinal cord, J. Physiol. (Lond.) 225: 44 P.
Coote, J. H., Hilton, S. M., and Zbroiyna, A. W., 1973, The pontomedullary area integrating the defence reaction in the cat and its influence on muscle blood flow, J. Physiol. (Lond.) 229: 257.
Corrodi, H., Fuxe, K., and Hökfelt, T., 1967, A possible role played by central monoamine neurons in thermo-regulation, Acta Physiol. Scand. 71: 224.
Corrodi, H., Fuke, K., Hökfelt, T., Lidbrink, P., and Ungerstedt, U., 1973, Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neurons, J. Pharm. Pharmacol. 25: 409.
Costa, E., 1956, Effects of hallucinogenic and tranquilizing drugs on serotonin evoked uterine contractions, Proc. Soc. Exptl. Biol. Med 91: 39.
Costa, E., and Zetler, G., 1959, Interactions between epinephrine and some psychotomimetic drugs, J. Pharmacol. Exptl. Therap. 125: 230.
Couch, J. R., 1970, Responses of neurons in the raphe nuclei to serotonin, norepinephrine and acetylcholine and their correlation with an excitatory synaptic input, Brain Res. 19: 137.
Cranley, J. J., Krause, R. J., Strasser, E. S., and Hafner, C. D., 1963, Impending gangrene of four extremities secondary to ergotism, New Engl. J. Med. 269: 727.
Cumings, J. N., and Hilton, B. P., 1971, Effects of methysergide on platelets incubated with reserpine, Brit. J. Pharmacol. 42: 611.
Curran, D. A., Hinterberger, H., and Lance, J. W., 1967, Methysergide, Res. Clin. Stud. Headache 1: 74.
Dalessio, D. J., 1972, Wolffs Headache and Other Head Pain, 3rd ed., Oxford University Press, New York.
Daughaday, W. H., and Jacobs, L. S., 1972, Human prolactin, Ergeb. Physiol. 67: 169.
Davidson, N., Edwardson, J. A., and Schwab, D. I., 1969, Agroclavine antagonises depression induced by noradrenaline in the cerebral cortex of the rat, Nature (Lond.) 223: 1166.
Davies, B. N., Horton, E. W., and Withrington, P. G., 1968, The occurrence of prostaglandin E2 in splenic venous blood of the dog following splenic nerve stimulation, Brit. J. Pharmacol. 32: 127.
de Groat, W. C., and Volle, R. L., 1966a, The actions of the catecholamines on transmission in the superior cervical ganglion of the cat, J. Pharmacol. Exptl. Therap. 154: 1.
de Groat, W. C., and Volle, R. L., 1966b, Interactions between the catecholamines and ganglionic stimulating agents in sympathetic ganglia, J. Pharmacol. Exptl. Therap. 154: 200.
Delay, J., and Thuillier, J., 1956, Dualite d’action du diethylamide de 1’acid lysergique sur la contraction uterine provoquee par la 5-hydroxytryptamine (Serotonine), Compt. Rend. Soc. Biol. 150: 1335.
Del Bianco, P. L., Franchi, G., Fanciullacci, M., and Sicuteri, F., 1972, Clinical pharmacology of 5-hydroxytryptamine and catecholamines venomotor receptors, Arch. Int. Pharmacodyn. Therap. 196: Suppl. 113.
Del Pozo, E., Brun del Re, R., Varga, L., and Friesen, H., 1972, The inhibition of prolactin secretion in man by CB154 (2-bromo-alpha-ergocryptine), J. Clin. Endocrinol. Metab. 35: 768.
Dengler, H. J., Spiegel, H. E., and Titus, E. O., 1961, Effects of drugs on uptake of isotopic norepinephrine by cat tissues, Nature (Lond.) 191: 816.
Der Marderosian, A., 1967, Hallucinogenic indole compounds from higher plants, Lloydia 30: 23.
Diaz, J.-L., and Huttunen, M. O., 1971, Persistent increase in brain serotonin turnover after chronic administration of LSD in the rat, Science 174: 62.
Dishotsky, N. I., Loughman, W. D., Mogar, R. E., and Lipscomb, W. R., 1971, LSD and genetic damage, Science 172: 431.
Downman, C. B. B., 1972, The vasomotor centre, in: Modern Trends in Physiology (Downman, C.B.B.,ed.) pp. 292–308, Butterworth, London.
Dyer, D. C., and Gant, D. W., 1973, Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature, J. Pharmacol. Exptl. Therap. 184: 366.
Eiduson, S., Geller, E., Yuwiler, A., and Eiduson, B. T., 1964, Biochemistry and Behavior, Van Nostrand, Princeton, N.J.
Erspamer, V., 1966, Peripheral physiological and pharmacological actions of indolealkylamines, Handbook Exptl. Pharmacol. 19: 245.
European Breast Cancer Group, 1972, Clinical trial of 2-Br-α-ergocryptine (CB 154) in advanced breast cancer, Europ. J. Cancer 8: 155.
Evarts, E. V., 1957, A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other psychotomimetic agents, Ann. N. Y. Acad. Sci. 66: 479.
Ezdinli, E. Z., Rouliah, J., Owens, G., and Sokal, J. E., 1968, Effect of high spinal cord section on epinephrine hyperglycemia, Am. J. Physiol. 214: 1019.
Fain, J. N., 1973, Biochemical aspects of drug and hormone action on adipose tissue, Pharmacol. Rev. 25: 67.
Fanchamps, A., Doepfner, W., Weidmann, H., and Cerletti, A., 1960, Pharmakologische Charakterisierung von Deseril, einem Serotonin-Antagonisten, Schweiz. Med. Wschr. 90: 1040.
Farnebo, L.-O., and Hamberger, B., 1971, Drug-induced changes in the release of [3H]-noradrenaline from field stimulated rat iris, Brit. J. Pharmacol. 43: 97.
Fedotin, M. S., and Hartmann, C., 1970, Ergotamine poisoning producing renal arterial spasm, New Engl. J. Med. 283: 518.
Florendo, N. T., Barrnett, R. J., and Greengard, P., 1971, Cyclic 3’,5 -nucleotide phosphodiesterase: Cytochemical localization in cerebral cortex, Science 173: 745.
Flückiger, E., and Wagner, H. R., 1968, 2-Br-α-ergokryptin: Beeinflussung von Fertilität und Laktation bei der Ratte, Experientia 24: 1130.
Fredholm, B., and Rosell, S., 1968, Effects of adrenergic blocking agents on lipid mobilization from canine subcutaneous adipose tissue after sympathetic nerve stimulation, J. Pharmacol. Exptl. Therap. 159: 1.
Freedman, D. X., 1963, Psychotomimetic drugs and brain biogenic amines, Am. J. Psychiat. 119: 843.
Freedman, D. X., 1969, The psychopharmacology of hallucinogenic agents, Ann. Rev. Med. 20: 409.
Freedman, D. X., Gottlieb, R., and Lovell, R. A., 1970, Psychotomimetic drugs and brain 5- hydroxytryptamine metabolism, Biochem. Pharmacol. 19: 1181.
Fregnan, G. B., and Glässer, A. H., 1968, Structure- activity relationship of various acyl derivatives of 6-methyl-8ß-aminomethyl-10α-ergoline (dihydrolysergamine), Experientia 24: 150.
Freis, E. D., Stanton, J. R., Litter, J., Culbertson, J. W., Halperin, M. H., Moister, F. C., and Wilkins, R. W., 1949, The hemodynamic effects of hypotensive drugs in man. II. Dihydroergocornine, J. Clin. Invest. 28: 1387.
Fuxe, K., and Owman, C., 1965, Cellular localization of monoamines in the area postrema of certain mammals, J. Comp. Neurol. 125: 337.
Fuxe, K., and Sjöqvist, F., 1972, Hypothermic effect of apomorphine in the mouse, J. Pharm. Pharmacol. 24: 702.
Gaddum, J. H., and Hameed, K. A., 1954, Drugs which antagonize 5-hydroxytryptamine. Brit. J. Pharmacol. 9: 240.
Gaddum, J. H., Hebb, C. O., Silver, A., and Swan, A. A. B., 1953, 5-Hydroxy try ptamine: Pharmacological action and destruction in perfused lungs, Quart. J. Exptl. Physiol. 38: 255.
Gessner, P. K., 1970, Pharmacological studies of 5-methoxy-N,N-dimethyltryptamine, LSD and other hallucinogens, in: Psychotomimetic Drugs ( Efron, D.H., ed.) pp. 105–118, Raven Press, New York.
Ginzel, K. H., and Kottegoda, S. R., 1953, A study of the vascular actions of 5- hydroxytryptamine, tryptamine, adrenaline and noradrenaline, Quart. J. Exptl. Physiol. 38: 225.
Gothelf, B., and Ellis, S., 1972, Effect of dihydroergotamine (DHE) on liver glycogenolysis and hyperglycemia induced by epinephrine, glucagon and cyclic AMP (cAMP) in the rat, in: Fifth International Congress of Pharmacology, San Francisco, p. 86 (abst.).
Graham, J. R., 1967, Methysergide, Practitioner 198:302:
Graham, J. R., Suby, H. I., Le Compte, P. M., and Sadowsky, N. L., 1967, Inflammatory fibrosis associated with methysergide therapy, Res. Clin. Stud. Headache 1: 123.
Greenfield, A. D. M., 1966, Survey of the evidence for active neurogenic vasodilatation in man, Fed. Proc. 25: 1607.
Haefely, W. E., 1969, Effects of catecholamines in the cat superior cervical ganglion and their postulated role as physiological modulators of ganglionic transmission, Prog. Brain Res. 31: 61.
Haeusler, G., 1973, Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of Clonidine, Naunyn-Schmiedeberg’s Arch. Pharmakol. 278: 231.
Haigler, H. J., and Aghajanian, G. K., 1972, Mescaline and LSD: Direct and indirect effects on serotonin-containing neurons in brain, Europ. J. Pharmacol. 21: 53.
Harvey, S. C., Wang, C.-Y., and Nickerson, M., 1951, Blockade of epinephrine-induced hyperglycemia, J. Pharmacol. Exptl. Therap. 104: 363.
Hasse, H. E., Scheifgen, W., and Schönhöfer, P. S., 1971, Notfallsituationen bei jugendlichen Drogenkonsumenten, Deutsch. Med. Wschr. 96: 449.
Hellon, R., 1972, Central transmitters and thermoregulation, in: Essays on Temperature Regulation ( Bligh, J., Moore, R.E., eds.) pp. 71–85, North-Holland, Amsterdam.
Heyck, H., 1969, Pathogenesis of migraine, Res. Clin. Stud. Headache 2: 1.
Hilton, B. P., and Cumings, J. N., 1972, 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache, J. Neurol. Neurosurg. Psychiat. 35: 505.
Himms-Hagen, J., 1970, Adrenergic receptors for metabolic responses in adipose tissue, Fed. Proc. 29: 1388.
Hoffer, A., and Osmond, H., 1967, The Hallucinogens, Academic Press, New York.
Hökfelt, T., and Fuxe, K., 1972a, On the morphology and the neuroendocrine role of the hypothalamic catecholamine neurons, in: Brain-Endocrine Interaction. Median Eminence: Structure and Function ( Knigge, K.M., Scott, D. E., Weindl, A., eds.) pp. 181–223, Karger, Basel.
Hökfelt, T., and Fuxe, K., 1912b, Effects of prolactin and ergot alkaloids on the tuberoinfundibular dopamine (DA) neurons, Neuroendocrinology 9: 100.
Hollister, L. E., 1972, Psychiatric syndromes due to drugs, in: Drug-Induced Diseases, Vol. 4 ( L. Meyler and H. M. Peck, eds.) pp. 561–570, Excerpta Medica, Amsterdam.
Horeyseck, G., Jänig, W., Kirchner, F., and Thämer, V., 1972, Electrophysiological studies on the hindlimb vasodilators on anesthesized cats, Pflügers Arch. 332: Suppl. R64.
Horita, A., and Dille, J. M., 1954, Pyretogenic effect of lysergic acid diethylamide, Science 120: 1100.
Horita, A., and Hamilton, A. E., 1973, The effects of DL-α-methyltyrosine and L-DOPA on the hyperthermic and behavioral actions of LSD in rabbits, Neuropharmacology, 12: 471.
Horn, G., and McKay, J. M., 1973, Effects of lysergic acid diethylamide on the spontaneous activity and visual receptive fields of cells in the lateral geniculate nucleus of the cat, Exptl. Brain. Res. 17: 271.
Hornbrook, K. R., 1970, Adrenergic receptors for metabolic responses in the liver, Fed. Proc. 29: 1381.
Hornbrook, K. R., and Brody, T. M., 1963, Phosphorylase activity in rat liver and skeletal muscle after catecholamines, Biochem. Pharmacol. 12: 1407.
Innes, I. R., 1962, Identification of the smooth muscle excitatory receptors for ergot alkaloids, Brit. J. Pharmacol. 19: 120.
Isbell, H., and Gorodetsky, C. W., 1966, Effect of alkaloids of ololiuqui in man, Psychopharmacologia (Berl.) 8: 331.
Isbell, H., and Logan, C. R., 1957, Studies on the diethylamide of lysergic acid. II. Effects of chlorpromazine, azacyclonol and reserpine on the intensity of the LSD-reaction, A.M.A. Arch. Neurol. Psychiat. 77: 350.
Isbell, H., Miner, E. J., and Logan, C. R., 1959, Relationships of psychotomimetic to antiserotonin potencies of congeners of lysergic acid diethylamide (LSD-25), Psychopharmacologia (Berl.) 1: 20.
Ito, A., and Schanberg, S. M., 1972, Central nervous system mechanisms responsible for blood pressure elevation induced by p-chlorphenylalanine, J. Pharmacol. Exptl. Therap. 181: 65.
Iwangoff, P., and Enz, A., 1972, The influence of various dihydroergotamine analogues on cyclic adenosine-3’,5’-monophosphate phosphodiesterase in the grey matter of cat brain in vitro, Agents and Actions 2: 223.
Jacobson, C. B., and Berlin, C. M., 1972, Possible reproductive detriment in LSD users, J.A.M.A. 222: 1367.
Jouvet, M., 1972, The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle, Ergeb. Physiol. 64: 166.
Karlsberg, P., Elliott, H. W., and Adams, J. E., 1963, Effect of various pharmacologic agents on cerebral arteries, Neurology 13: 772.
Katz, R. I., and Kopin, I. J., 1969, Effect of D-LSD and related compounds on release of norepinephrine-H3 and serotonin-H3 evoked from brain slices by electrical stimulation, Pharmacol. Res. Commun. 1: 54.
Kebabian, J. W., and Greengard, P., 1971, Dopamine-sensitive adenyl cyclase: Possible role in synaptic transmission, Science 174: 1346.
Key, B. J., 1965a, Effect of lysergic acid diethylamide on potentials evoked in the specific sensory pathways, Brit. Med. Bull. 21: 30.
Key, B. J., 19656, The effects of drugs in relation to the afferent collateral system of the brain stem, Electroenceph. Clin. Neurophysiol. 18: 670.
King, A. R., Seymour, K. A., and Martin, I. L., 1972, Reversal learning enhanced by LSD 25: Correlation with levels of brain amines, Psychopharmacologia (Ber.) 26: Suppl. 121.
Koella, W. P., 1969, Neurohumoral aspects of sleep control, Biol. Psychiat. 1: 161.
Konzett, H., 1960, Specific antagonism of dibenamine to ergometrine, in: Adrenergic Mechanisms, CIBA Foundation Symposium ( Vane, J.R., Wolstenholme, G.E.W., O’Connor, M., eds.) pp. 463–465, J. & A. Churchill, London.
Konzett, H., and Rothlin, E., 1953, Investigations on the hypotensive effect of the hydrogenated ergot alkaloids, Brit. J. Pharmacol. 8: 201.
Kovalyov, G. V., 1967, Localization and characteristics of the influence of some neurotropic drugs on the bulbar vasomotor centre, Prog. Brain Res. 20: 187.
Krnjević, K., and Phillis, J. W., 1963, Actions of certain amines on cerebral cortical neurones, Brit. J. Pharmacol. 20: 471.
Levy, B., and Ahlquist, R. P., 1961, An analysis of adrenergic blocking activity, J. Pharmacol. Exptl. Therap. 133: 202.
Levy, B., and Tozzi, S., 1963, The adrenergic receptive mechanism of the rat uterus, J. Pharmacol. Exptl. Therap. 142: 178.
Lewis, P. J., and Lee, M. R., 1972, Renin release in the rabbit produced by ergometrine infusion, Brit. J. Exptl. Pathol. 53: 150.
Libet, B., 1970, Generation of slow inhibitory and excitatory postsynaptic potentials, Fed. Proc. 29: 1945.
Lin, R. C., Ngai, S. H., and Costa, E., 1969, Lysergic acid diethylamide: Role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine), Science 166: 237.
Lomax, P., and Schönbaum, E. (eds.), 1973, The Pharmacology of Thermoregulation, Karger, Basel.
Long, S. Y., 1972, Does LSD induce chromosomal damage and malformations? A review of the literature, Teratology 6: 75.
Mabry, P. O., and Campbell, B. A., 1973, Serotonergic inhibition of catecholamine-induced behavioral arousal, Brain Res. 49: 381.
McCann, S. M., Kalra, P. S., Donoso, A. O., Bishop, W., Schneider, H. P. G., Fawcett, C. P., and Krulich, L., 1972, The role of monoamines in the control of gonado-tropin and prolactin secretion, in: Brain-Endocrine Interaction. Median Eminence: Structure and Function ( Knigge, K.M., Scott, D.E., Weindl, A., eds.) pp. 224–235, Karger, Basel.
McCulloch, M. W., Rand, M. J., and Story, D. F., 1972, Inhibition of 3H-noradrenaline release from sympathetic nerves of guinea-pig atria by a presynaptic α-adrenoceptor mechanism, Brit. J. Pharmacol. 46: 523.
Meites, J., and Clemens, J. A., 1972, Hypothalamic control of prolactin secretion, Vitam. Horm. 30: 165.
Meites, J., Lu, K. H,. Wuttke, W., Welsch, C. W., Nagasawa, H., and Quadri, S. K., 1972, Recent studies on functions and control of prolactin secretion in rats, Ree. Prog. Horm. Res. 28: 471.
Meldrum, B. S., and Naquet, R., 1971, Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio), Electroenceph. Clin. Neurophysiol. 31: 563.
Mellander, S., and Johansson, B., 1968, Control of resistance, exchange and capacitance functions in the peripheral circulation, Pharmacol. Rev. 20: 117.
Mellander, S., and Nordenfeit, I., 1970, Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation, Clin. Sci. 39: 183.
Miller, J. W., 1967, Adrenergic receptors in the myometrium, Ann. N.Y. Acad. Sci. 139: 788.
Miller, M. D., and Marshall, J. M., 1965, Uterine response to nerve stimulation; relation to hormonal status and catecholamines, Am. J. Physiol. 209: 859.
Monachon, M.-A., Burkard, W. P., Jalfre, M., and Haefely, W., 1972, Blockade of central 5- hydroxytryptamine receptors by methiothepin, Naunyn-Schmiedeberg’s Arch. Pharmakol. 274: 192.
Morest, D. K., 1967, Experimental study of the projections of the nucleus of the tractus solitarius and the area postrema of the cat, J. Comp. Neurol. 130: 277.
Morgane, P. J., and Stern, W. C., 1972, Relationship of sleep to neuroanatomical circuits, biochemistry and behavior, Ann. N.Y. Acad. Sci. 193: 95.
Murad, F., Chi, Y.M., Rail, T. W., and Sutherland, E. W., 1962, Adenyl cyclase III: The effect of catecholamines and choline esters on the formation of adenosine 3’,5’-phosphate by preparations from cardiac muscle and liver, J. Biol. Chem. 237: 1233.
Nakano, J., Ishii, T., Oliver, R. D., and Gin, A. C., 1969, Effect of dihydroergotamine and propranolol on dibutyryl cyclic 3’,5’-AMP-induced lipolysis in isolated rat fat cells, Proc. Soc. Exptl. Biol. Med. 132: 150.
Nichols, W. W., 1972, The relationship of chromosome aberrations to drugs, in: Drug-Induced Diseases, Vol. 4 ( L. Meyler and H. M. Peck, eds.) pp. 60–80, Excerpta Medica, Amsterdam.
Nishi, S,. 1970, Cholinergic and adrenergic receptors at sympathetic preganglionic nerve terminals, Fed. Proc. 29: 1957.
Northrop, G., and Parks, R. E., Jr., 1964, The effects of adrenergic blocking agents and theophylline on 3’,5’-AMP-induced hyperglycemia, J. Pharmacol. Exptl. Therap. 145: 87.
Owen, D. A. A., and Stuermer, E., 1971, Effect of dihydroergotamine (DHG) on the capacitance, resistance and precapillary sphincter vessels of denervated cat skeletal muscle, Brit. J. Pharmacol. 42: 655.
Owen, D. A. A., and Stuermer, E., 1972, The effects of Hydergine on acutely denervated cat skeletal muscle vasculature, Nauyn-Schmiedeberg’s Arch. Pharmakol. 272: 395.
Pacha, W., and Salzmann, R., 1970, Inhibition of the re-uptake of neuronally liberated noradrenaline and a-receptor blocking action of some ergot alkaloids, Brit. J. Pharmacol. 38: 439.
Palmer, G. C., and Burks, T. F., 1971, Central and peripheral adrenergic blocking actions of LSD and BOL, Europ. J. Pharmacol. 16: 113.
Porter, J. C., Kamberi, I. A., and Ondo, J. G., 1972, Role of biogenic amines and cerebrospinal fluid in the neurovascular transmittal of hypophysiotrophic substances, in: Brain-Endocrine Interaction. Median Eminence: Structure and Function ( Knigge, K.M., Scott, D. E., Weindl, A., eds.) pp. 245–253, Karger, Basel.
Purpura, D. P., 1957, Experimental analysis of the inhibitory action of lysergic acid diethylamide on cortical dendritic activity, Ann. N.Y. Acad. Sci. 66: 515.
Ramstad, E., 1968, Chemistry of alkaloid formation in ergot, Lloydia 31: 327.
Richardson, B. P., 1973, Evidence for a physiological role of prolactin in osmoregulation in the rat after its inhibition by 2-bromo-α-ergokryptine, Brit. J. Pharmacol. 47: 623.
Roberts, M. H. T., and Straughan, D. W., 1967, Excitation and depression of cortical neurones by 5-hydroxytryptamine, J. Physiol. (Lond.) 193: 269.
Rosenberg, F. J., and DiStefano, V., 1962, A central nervous system component of epinephrine hyperglycemia, Am. J. Physiol. 203: 782.
Rothlin, E., 1947, The pharmacology of the natural and dihydrogenated alkaloids of ergot, Bull. Schweiz. Akad. Med. Wiss. 2: 249.
Rothlin, E., 1957, Pharmacology of lysergic acid diethylamide and some of its related compounds, J. Pharm. Pharmacol. 9: 569.
Rothlin, E., Konzett, H., and Cerletti, A., 1954, The antagonism of ergot alkaloids towards the inhibitory response of the isolated rabbit intestine to epinephrine and norepinephrine, J. Pharmacol. Exptl. Therap. 112: 185.
Salmoiraghi, G. C., McCubbin. J. W., and Page, I. H., 1957, Effects of d-lysergic acid diethylamide and its brom derivative on cardiovascular responses to serotonin and on arterial pressure, J. Pharmacol. Exptl. Therap. 119: 240.
Samanin, R., Valzelli, L., and Gumulka, W., 1972, Inhibitory effect of midbrain raphe stimulation on cortical evoked potentials in rats, Psychopharmacologia (Berl.) 24: 373.
Savini, E. C., 1956, The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid, Brit. J. Pharmacol. 11: 313.
Saxena, P. R., 1972, The effects of antimigraine drugs on the vascular responses by 5- hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: Possible pharmacological implications to their antimigraine action, Headache 12: 44.
Schally, A. V., Arimura, A., and Kastin, A. J., 1973, Hypothalamic regulatory hormones, Science 179: 341.
Schmitt, H., and Fenard, S., 1970, Effects des alcaloides de l’ergot de seigle sur les centres vasomoteurs et leur inhibition par la Clonidine, Compt. Rend. Soc. Biol. 164: 1006.
Shaar, C. J., and Clemens, J. A., 1972, Inhibition of lactation and prolactin secretion in rats by ergot alkaloids, Endocrinology 90: 285.
Share, N. N., 1973, “Alpha” and “beta” adrenergic receptors in the medullary vasomotor center of the cat, Arch. Int. Pharmacodyn. Therap. 202:362.
Shemano, I., and Nickerson, M., 1958, Effect of ambient temperature on thermal responses to drugs, Can. J. Biochem. Physiol. 36: 1243.
Shields, P. J., and Eccleston, D., 1973, Evidence for the synthesis and storage of 5- hydroxytryptamine in two separate pools in the brain, J. Neurochem. 20: 881.
Sicuteri, F., 1967, Vasoneuractive substances and their implication in vascular pain, Res. Clin. Stud. Headache 1: 6.
Sicuteri, F., Buffoni, F., Anselmi, B., and Del Bianco, P. L., 1972, An enzyme (MAO) defect on the platelets in migraine, Res. Clin. Stud. Headache 3: 245.
Sicuteri, F., Anselmi, B., and Del Bianco, P. L., 1973, 5-Hydroxytryptamine supersensitivity as a new theory of headache and central pain: A clinical pharmacological approach with N-chlorophenylalanine, Psychopharmacologia (Berl.) 29: 347.
Simmonds, M. A., 1970, Effect of environmental temperature on the turnover of 5- hydroxytryptamine in various areas of rat brain, J. Physiol. (Lond.) 211: 93.
Smart, R. G., and Bateman, K., 1967, Unfavourable reactions on LSD: A review and analysis of the available case reports, Can. Med. Ass. J. 97: 1214.
Starke, K., 1972, Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart, Naunyn-Schmiedeberg’s Arch. Pharmakol. 274: 18.
Stern, W. C., Morgane, P. J., and Bronzino, J. D., 1972, LSD: Effects on sleep patterns and spiking activity in the lateral geniculate nucleus, Brain Res. 41: 199.
Stjärne, L., 1973, Alpha-adrenoceptor mediated feedback control of sympathetic neurotransmitter secretion in guinea-pig vas deferens, Nature New Biol. 241: 190.
Stöll, B. A., 1972, Brain catecholamines and breast cancer: A hypothesis, Lancet 1: 431.
Stone, T. W., 1973, Studies on the central nervous system effects of agroclavine, an ergot alkaloid, Arch. Int. Pharmacodyn. Therap. 202: 62.
Tabushi, K., and Himwich, H. E., 1971, Electroencephalographic study of the effects of methysergide on sleep in the rabbit, Electroenceph. Clin. Neurophysiol. 31: 491.
Taylor, R. L., Maurer, J. I., and Tinklenberg, J. R., 1970, Management of “bad trips” in an evolving drug scene, J.A.M.A.2\3mA22.
Tebecis, A. K., and Di Maria, A., 1972, A re-evaluation of the mode of action of 5- hydroxytryptamine on lateral geniculate neurones: Comparison with catecholamines and LSD, Exptl. Brain. Res. 14: 480.
Ulrich, J., and Siggaard-Andersen, J., 1972, Vascular effects of dihydrogenated ergot alkaloids: Comparative effects of dihydroergostine and dihydroergotamine on the blood flow and the capacitance vessels in the human calf studied by plethysmography, Angiology 22: 622.
Uvnäs, B., 1960, Central cardiovascular control, in: Handbook of Physiology, Section 1: Neurophysiology, Vol. II ( J. Field, ed.) pp. 1131–1162, American Physiological Society, Washington, D.C.
Voss, E. W., Jr., Babb, J. E., Metzel, P., and Winkelhake, J. L., 1973, In vitro effect of d-lysergic acid diethylamide on immunoglobulin synthesis, Biochem. Biophys. Res. Commun. 50: 950.
Vuillon-Cacciuttolo, G., and Balzano, E., 1972, Action de quatre derives de Pergot sur la photosensibilite de l’E.E.G. du Papio papio, J. Pharmacol. (Paris) 3: 31.
Walter, S., Balzano, E., Vuillon-Cacciuttolo, G., and Naquet, R., 1971, Effets comportementaux et electrographiques du diethylamide de l’acide D-lysergique (LSD-25) sur le Papio papio photosensible, Electroenceph. Clin. Neurophysiol. 30: 294.
Wang, S. C., 1965, Emetic and antiemetic drugs, in: Physiological Pharmacology, Vol. 2 ( Root, W.S., Hofmann, F. G., eds.) pp. 255–328, Academic Press, London.
Weiss, B. L., and Aghajanian, G. K., 1971, Activation of brain serotonin metabolism by heat: Role of midbrain raphe neurons, Brain Res. 26: 37.
White, R. P., Heaton, J. A., and Denton, I. C., 1971, Pharmacological comparison of prostaglandin F2α, serotonin and norepinephrine on cerebrovascular tone of monkey, Europ. J. Pharmacol. 15: 300.
Whitney, B., 1965, A preliminary investigation of the pharmacology of longitudinal muscle strips from human isolated jejunum, J. Pharm. Pharmacol. 17: 465.
Willems, J. L., 1972, On the pharmacology of autonomic ganglia, Arch. Int. Pharmacodyn. Therap. 196: Suppl. 244.
Wuttke, W., Cassell, E. and Meites, J., 1971, Effects of ergocornine on serum prolactin and LH, and on hypothalamic contents of PIF and LRF, Endocrinology, 88: 737.
Ylitalo, P., Tammisto, T., and Pohto, P., 1970, Effect of anaesthesia on the behaviour of exogenous 5HT in area postrema of rat and mouse brain studied by fluorescence microscopy, Ann. Med. Exptl. Fenn. 48: 94.
Yui, T., and Takeo, Y., 1958, Neuropharmacological studies on a new series of ergot alkaloids, Jap. J. Pharmacol. 7: 157.
Yui, T., and Takeo, Y., 1964, Increase in anti-5HT activity by 1-methylation of clavine-type ergot alkaloids, Jap. J. Pharmacol. 14: 107.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Plenum Press, New York
About this chapter
Cite this chapter
Bradley, P.B., Briggs, I. (1974). Ergot Alkaloids and Related Substances. In: Simpson, L.L., Curtis, D.R. (eds) Poisons of Plant Origin. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2943-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2943-5_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2945-9
Online ISBN: 978-1-4684-2943-5
eBook Packages: Springer Book Archive